| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sutro Biopharma Inc (NASDAQ: STRO)
STRO Technical Analysis
5
| As on 3rd Dec 2025 STRO SHARE Price closed @ 8.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.18 & Strong Buy for SHORT-TERM with Stoploss of 2.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
STROSHARE Price
| Open | 7.75 | Change | Price | % |
| High | 8.91 | 1 Day | 7.97 | 1091.78 |
| Low | 7.15 | 1 Week | 7.86 | 935.71 |
| Close | 8.70 | 1 Month | 7.50 | 625.00 |
| Volume | 175077 | 1 Year | 6.05 | 228.30 |
| 52 Week High 8.70 | 52 Week Low 0.52 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| IRBT | 3.39 | 73.85% |
| NVDA | 179.59 | -1.03% |
| ONDS | 8.92 | 10.53% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.23 | 5.69% |
| AKTS | 0.04 | 0.00% |
| TSLA | 446.74 | 4.08% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| STRO Daily Charts |
STRO Intraday Charts |
Whats New @ Bazaartrend |
STRO Free Analysis |
|
|
STRO Important Levels Intraday
| RESISTANCE | 12.09 |
| RESISTANCE | 11.00 |
| RESISTANCE | 10.33 |
| RESISTANCE | 9.66 |
| SUPPORT | 7.74 |
| SUPPORT | 7.07 |
| SUPPORT | 6.40 |
| SUPPORT | 5.31 |
STRO Forecast December 2025
| 4th UP Forecast | 11.28 |
| 3rd UP Forecast | 10.45 |
| 2nd UP Forecast | 9.94 |
| 1st UP Forecast | 9.43 |
| 1st DOWN Forecast | 7.97 |
| 2nd DOWN Forecast | 7.46 |
| 3rd DOWN Forecast | 6.95 |
| 4th DOWN Forecast | 6.12 |
STRO Weekly Forecast
| 4th UP Forecast | 10.49 |
| 3rd UP Forecast | 9.92 |
| 2nd UP Forecast | 9.56 |
| 1st UP Forecast | 9.21 |
| 1st DOWN Forecast | 8.19 |
| 2nd DOWN Forecast | 7.84 |
| 3rd DOWN Forecast | 7.48 |
| 4th DOWN Forecast | 6.91 |
STRO Forecast2025
| 4th UP Forecast | 24.87 |
| 3rd UP Forecast | 19.68 |
| 2nd UP Forecast | 16.48 |
| 1st UP Forecast | 13.27 |
| 1st DOWN Forecast | 4.13 |
| 2nd DOWN Forecast | 0.92 |
| 3rd DOWN Forecast | -2.28 |
| 4th DOWN Forecast | -7.47 |
Sutro Biopharma Inc ( NASDAQ USA Symbol : STRO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
STRO Business Profile
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California. Address: 310 Utah Avenue, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service